Federal Contractor Profile
Regeneron Pharmaceuticals INC
$6.6B obligated·12 awards·3 agencies·3 NAICS
Federal Contracts
Showing contracts 1–24 of 24 total. Sorted by action date, most recent first. Excludes $0 modifications.
| Date | Agency | PIID | NAICS | Description | Amount |
|---|---|---|---|---|---|
| Aug 21, 2023 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201700020C | 541711 | IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD | $326M |
| Nov 24, 2021 | Department of Veterans Affairs241-NETWORK CONTRACT OFFICE 01 (36C241) | 36C24122N0160 | 325412 | EVKEEZA DRUG | $494K |
| Sep 14, 2021 | Department of DefenseW6QK ACC-APG NATICK | W15QKN21C0014 | 325414 | PRODUCTION OF THERAPEUTIC IN SUPPORT OF NATIONAL EMERGENCY RESPONSE TO CORONAVIRUS 2019 (COVID-19): IN SUPPORT OF OPERATION WARP SPEED (OWS), THE GOVERNMENT IS PURCHASING UP TO 1,250,000 DOSES OF THE EMERGENCY USE AUTHORIZATION (EUA) THERAPEUTIC. | $2.9B |
| Sep 8, 2021 | Department of Veterans Affairs241-NETWORK CONTRACT OFFICE 01 (36C241) | 36C24121F0292 | 325412 | EVKEEZA | $148K |
| Jan 12, 2021 | Department of DefenseW6QK ACC-PICA | W15QKN21C0014 | 325414 | PRODUCTION OF THERAPEUTIC IN SUPPORT OF NATIONAL EMERGENCY RESPONSE TO CORONAVIRUS 2019 (COVID-19): IN SUPPORT OF OPERATION WARP SPEED (OWS), THE GOVERNMENT IS PURCHASING UP TO 1,250,000 DOSES OF THE EMERGENCY USE AUTHORIZATION (EUA) THERAPEUTIC. | $2.6B |
| Jul 25, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201700016C | 541711 | IGF::OT::IGF | $345M |
| Jun 18, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201700020C | 541711 | IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD | $54M |
| Jun 15, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201700020C | 541711 | IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD | $85M |
| Apr 29, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201700020C | 541711 | IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD | $9.2M |
| Apr 23, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201700016C | 541711 | IGF::OT::IGF | $47M |
| Mar 21, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201700020C | 541711 | IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD | $93M |
| Jan 31, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201700020C | 541711 | IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD | $5.8M |
| Sep 25, 2019 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201700016C | 541711 | IGF::OT::IGF | $23M |
| Sep 12, 2019 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201700020C | 541711 | IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD | $20M |
| May 22, 2019 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201700016C | 541711 | IGF::OT::IGF | $132M |
| Aug 13, 2018 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201700016C | 541711 | IGF::OT::IGF | $53M |
| May 9, 2018 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201700016C | 541711 | IGF::OT::IGF | $26M |
| Feb 13, 2018 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201700016C | 541711 | IGF::OT::IGF | $28M |
| Sep 28, 2017 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201700016C | 541711 | IGF::OT::IGF | $40M |
| Sep 21, 2017 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201700020C | 541711 | IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD | $19M |
| May 31, 2017 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201500013C | 541711 | REGENERON-ANTI-EBOLA ANTIBODY THERAPEUTICS PROGRAM DEVELOPMENT IGF::OT::IGF | $15M |
| Nov 23, 2016 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201600023C | 541711 | IGF::OT::IGF | $7.2M |
| Aug 12, 2016 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201600023C | 541711 | IGF::OT::IGF | $1.8M |
| Oct 21, 2015 | Department of Health and Human ServicesOFF ASST SEC ADM AND MGMT | HHSO100201500013C | 541711 | REGENERON-ANTI-EBOLA ANTIBODY THERAPEUTICS PROGRAM DEVELOPMENT IGF::OT::IGF | $2.4M |
Get Alerted Before Regeneron Pharmaceuticals INC's Next Recompete
Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.
Start Free